Molecular predictors of response and outcome in ovarian cancer
- 1 October 2006
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 60 (1) , 19-37
- https://doi.org/10.1016/j.critrevonc.2006.03.003
Abstract
No abstract availableKeywords
This publication has 168 references indexed in Scilit:
- REporting recommendations for tumour MARKer prognostic studies (REMARK)European Journal Of Cancer, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- Gene expression arrays in cancer research: methods and applicationsCritical Reviews in Oncology/Hematology, 2005
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumorsNature Medicine, 2003
- Mass spectrometry-based proteomicsNature, 2003
- Part I: Chemotherapy for epithelial ovarian cancer–treatment at first diagnosisThe Lancet Oncology, 2002
- Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to α-folate receptor overexpressionOncogene, 2000
- The Hallmarks of CancerCell, 2000